Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-89.94%
0%
-89.94%
6 Months
-87.46%
0%
-87.46%
1 Year
-96.64%
0%
-96.64%
2 Years
-99.33%
0%
-99.33%
3 Years
-99.32%
0%
-99.32%
4 Years
-99.66%
0%
-99.66%
5 Years
-99.71%
0%
-99.71%
European Institute of Science AB for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
10.26%
EBIT Growth (5y)
2.68%
EBIT to Interest (avg)
-2.63
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
0.29
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
0.14
EV to EBITDA
0.14
EV to Capital Employed
-0.07
EV to Sales
-0.35
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-50.89%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Mar 2023
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 0 Foreign Institutions (0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Sep'24 - YoY
Sep'24
Sep'23
Change(%)
Net Sales
0.30
0.10
200.00%
Operating Profit (PBDIT) excl Other Income
-0.60
-0.70
14.29%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.60
-0.70
14.29%
Operating Profit Margin (Excl OI)
-2,288.80%
-6,428.60%
413.98%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2024 is 200.00% vs 0.00% in Sep 2023
Consolidated Net Profit
YoY Growth in quarter ended Sep 2024 is 14.29% vs 0.00% in Sep 2023
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
0.60
0.50
20.00%
Operating Profit (PBDIT) excl Other Income
-2.80
-2.70
-3.70%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-2.70
-2.70
Operating Profit Margin (Excl OI)
-4,612.10%
-5,160.10%
54.80%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 20.00% vs 0.00% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 0.00% vs -8.00% in Dec 2022
About European Institute of Science AB 
European Institute of Science AB
Electronic Equipment/Instruments
European Institute of Science AB (EURIS) is a Sweden-based commercial research center. The Company, through its wholly owned subsidiary, ScienceHouse Lund AB is engaged in the research, development, manufacturing, sales and marketing of medical technology, health care, cosmetics and personal care, biotechnology, energy, education and entertainment products and methods. Additionally, it is engaged in the investment in high-technology companies, as well as in leasing and management of properties. As of December 31, 2011, the Company’s investments and project royalties included LifeAssays AB (publ), Biotech-IgG AB and Implementa Hebe AB (publ). The Company’s products include liquid chromatography equipment for affinity purification of proteins and antibodies, and a range of products obtained from pooled human or animal plasma.
Company Coordinates 
Company Details
Ideongatan 1A , LUND None : 223 70
Registrar Details






